• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诃子(Terminalia arjuna Wight & Arn.)——一种治疗心血管疾病的有效药物。

Terminalia arjuna Wight & Arn.--a useful drug for cardiovascular disorders.

作者信息

Dwivedi Shridhar

机构信息

Preventive Cardiology Group, University College of Medical Sciences, University of Delhi, Delhi 110095, India.

出版信息

J Ethnopharmacol. 2007 Nov 1;114(2):114-29. doi: 10.1016/j.jep.2007.08.003. Epub 2007 Aug 10.

DOI:10.1016/j.jep.2007.08.003
PMID:17875376
Abstract

Ancient Indian physicians used the powdered tree bark of Terminalia arjuna Wight & Arn. for alleviating "hritshool" (angina) and other cardiovascular conditions. Its stem bark possesses glycosides, large quantities of flavonoids, tannins and minerals. Flavonoids have been detected to exert antioxidant, anti-inflammatory and lipid lowering effects while glycosides are cardiotonic, thus making Terminalia arjuna unique amongst currently used medicinal plants. In this review an attempt has been made to discuss various aspects of its ethnomedical, pharmacognostical, phytochemical, pharmacological and clinical relevance to cardiovascular conditions. Experimental studies have revealed its bark exerting significant inotropic and hypotensive effect, increasing coronary artery flow and protecting myocardium against ischemic damage. It has also been detected to have mild diuretic, antithrombotic, prostaglandin E(2) enhancing and hypolipidaemic activity. There is ample clinical evidence of its beneficial effect in coronary artery disease alone and along with statin. However, toxicological studies in experimental animals are lacking. Considering its anti-ischemic activity and its potential to correct dyslipidemia, reduce left ventricular mass and increase left ventricular ejection fraction, it is essential to examine the molecular mechanism of its action and its core constituents. Proposition to administer Terminalia arjuna along with statins deserves to be explored in depth for defining its place in the over all management and prevention of coronary artery disease.

摘要

古印度医生使用诃子(Terminalia arjuna Wight & Arn.)的树皮粉末来缓解“hritshool”(心绞痛)和其他心血管疾病。其茎皮含有糖苷、大量黄酮类化合物、单宁和矿物质。已检测到黄酮类化合物具有抗氧化、抗炎和降血脂作用,而糖苷具有强心作用,因此诃子在目前使用的药用植物中独树一帜。在本综述中,我们试图讨论其在民族医学、生药学、植物化学、药理学以及与心血管疾病临床相关性的各个方面。实验研究表明,其树皮具有显著的变力和降压作用,可增加冠状动脉血流量并保护心肌免受缺血损伤。还检测到它具有轻度利尿、抗血栓形成、增强前列腺素E2和降血脂活性。有充分的临床证据表明,它单独或与他汀类药物联合使用对冠状动脉疾病具有有益作用。然而,缺乏对实验动物的毒理学研究。鉴于其抗缺血活性以及纠正血脂异常、减轻左心室质量和增加左心室射血分数的潜力,有必要研究其作用的分子机制及其核心成分。对于在冠状动脉疾病的整体管理和预防中确定其地位而言,将诃子与他汀类药物联合使用的提议值得深入探讨。

相似文献

1
Terminalia arjuna Wight & Arn.--a useful drug for cardiovascular disorders.诃子(Terminalia arjuna Wight & Arn.)——一种治疗心血管疾病的有效药物。
J Ethnopharmacol. 2007 Nov 1;114(2):114-29. doi: 10.1016/j.jep.2007.08.003. Epub 2007 Aug 10.
2
Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation.没食子诃子在冠状动脉疾病中的应用:民族药理学、临床前、临床和安全性评价。
J Ethnopharmacol. 2014 Sep 11;155(2):1029-45. doi: 10.1016/j.jep.2014.06.056. Epub 2014 Jul 8.
3
Therapeutic potential of Terminalia arjuna in cardiovascular disorders.诃子在心血管疾病中的治疗潜力。
Am J Cardiovasc Drugs. 2012 Jun 1;12(3):157-63. doi: 10.2165/11598990-000000000-00000.
4
The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes.没食子酸柯树皮的水提物而非有机溶剂提取物对成年心室肌细胞发挥正性肌力作用。
Phytomedicine. 2011 Feb 15;18(4):259-65. doi: 10.1016/j.phymed.2010.07.006.
5
Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats.榄仁树植物成分对大鼠伤口愈合活性的评估。
Phytother Res. 2006 Sep;20(9):799-805. doi: 10.1002/ptr.1857.
6
Terminalia arjuna in cardiovascular diseases: making the transition from traditional to modern medicine in India.诃子在心血管疾病中的应用:印度传统医学向现代医学的转变。
Curr Pharm Biotechnol. 2010 Dec;11(8):855-60. doi: 10.2174/138920110793262051.
7
Therapeutic potential and industrial applications of Terminalia arjuna bark.诃子树皮的治疗潜力及工业应用
J Ethnopharmacol. 2023 Jun 28;310:116352. doi: 10.1016/j.jep.2023.116352. Epub 2023 Mar 16.
8
Terminalia arjuna.诃子
Altern Med Rev. 1999 Dec;4(6):436-7.
9
Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial.诃子(Terminalia arjuna (Roxb. ex DC.) Wight & Arn.)树皮水提取物对慢性心力衰竭患者的临床疗效:一项双盲、随机对照试验。
Phytomedicine. 2016 Oct 15;23(11):1211-9. doi: 10.1016/j.phymed.2016.02.007. Epub 2016 Feb 23.
10
Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia.诃子不同部位提取物抗PX - 407诱导的高脂血症的降血脂及抗氧化潜力
Indian J Exp Biol. 2011 Apr;49(4):282-8.

引用本文的文献

1
Investigation of Aloe vera mediated ZnO-β-CD nanocomposite for photocatalysis and antimicrobial applications.用于光催化和抗菌应用的芦荟介导的ZnO-β-环糊精纳米复合材料的研究。
Sci Rep. 2025 Jul 2;15(1):22871. doi: 10.1038/s41598-025-05231-6.
2
Clinical study evaluating antihyperglycemic efficacy and safety of versus sitagliptin in Type-2 diabetes mellitus patients.评估[药物名称]与西他列汀相比在2型糖尿病患者中的降糖疗效和安全性的临床研究。 (注:原文中“versus sitagliptin”前缺失具体药物名称)
Bioinformation. 2024 Dec 31;20(12):1862-1868. doi: 10.6026/9732063002001862. eCollection 2024.
3
A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies.
心血管疾病管理的综合述评:心脏生物标志物、成像方式、药物治疗、手术干预和草药疗法。
Cells. 2024 Sep 1;13(17):1471. doi: 10.3390/cells13171471.
4
Evaluation of In Vitro Antimicrobial, Cytotoxic, Thrombolytic, and Antiarthritic Property of Different Parts of Bari Orchid.巴里兰花不同部位的体外抗菌、细胞毒性、溶栓和抗关节炎特性评估
Evid Based Complement Alternat Med. 2024 Apr 30;2024:8148610. doi: 10.1155/2024/8148610. eCollection 2024.
5
Investigation of the antimicrobial, antioxidant, hemolytic, and thrombolytic activities of , , and ethanolic and methanolic extracts.对[具体物质]的乙醇提取物和甲醇提取物的抗菌、抗氧化、溶血和溶栓活性进行研究。 (你提供的原文中“ , , and ”部分内容缺失,请补充完整以便更准确翻译)
Food Sci Nutr. 2023 Jul 24;11(10):6303-6311. doi: 10.1002/fsn3.3569. eCollection 2023 Oct.
6
Multitarget Potential of Phytochemicals from Traditional Medicinal Tree, (Roxb. ex DC.) Wight & Arnot as Potential Medicaments for Cardiovascular Disease: An In-Silico Approach.传统药用树木(Roxb. ex DC.)Wight & Arnott 中植物化学物质的多靶点潜力:心血管疾病潜在药物的计算方法。
Molecules. 2023 Jan 20;28(3):1046. doi: 10.3390/molecules28031046.
7
GC-MS and Network Pharmacology Analysis of the Ayurvedic Fermented Medicine, Chandanasava, Against Chronic Kidney and Cardiovascular Diseases.基于 GC-MS 和网络药理学分析阿育吠陀发酵药物 Chandanasava 对慢性肾脏病和心血管疾病的作用。
Appl Biochem Biotechnol. 2023 May;195(5):2803-2828. doi: 10.1007/s12010-022-04242-7. Epub 2022 Nov 23.
8
KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicine.单宁激活 KCNQ5 介导美洲原住民植物药树皮的血管舒张作用。
FASEB J. 2022 Sep;36(9):e22457. doi: 10.1096/fj.202200724R.
9
Antiviral Potential of Selected Medicinal Herbs and Their Isolated Natural Products.精选草药及其分离天然产物的抗病毒潜力。
Biomed Res Int. 2021 Dec 8;2021:7872406. doi: 10.1155/2021/7872406. eCollection 2021.
10
An evaluation of pharmacological healing potentialities of against several ailments on experimental rat models with an in-silico approach.采用计算机模拟方法对[具体药物]在实验大鼠模型上针对多种疾病的药理治疗潜力进行评估。 (注:原文中“against several ailments”前缺少具体药物名称,这里用[具体药物]代替以便完整表达意思)
Heliyon. 2021 Oct 20;7(11):e08225. doi: 10.1016/j.heliyon.2021.e08225. eCollection 2021 Nov.